Xconomy’s Digital Events →
September 21, 2020 · National
September 24, 2020 · National
November 17, 2020 · New York
Sarah Karlin-Smith covers regulation of the pharmaceutical industry for the Pink Sheet.
It will be difficult to compare Moderna, Inc. and Pfizer Inc.’s coronavirus vaccines based on their Phase 3 study designs, some vaccines experts said.
“Both trials appeared to be well designed,”... Read more »
Fast enrollment of the right patient populations will be critical to quickly conducting Phase III trials of COVID-19 vaccines and this will likely mean taking concerted steps to reach out to... Read more »
The US Health and Human Services agency isn’t ready to go all in on “pull” incentives to encourage the development of new antibiotics, the agency indicated in response to a new... Read more »
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.